Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX was delisted on the 6th of March, 2020.
77 hedge funds and large institutions have $127M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 41 increasing their positions, 14 reducing their positions, and 14 closing their positions.
193% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 84 → 77 (-7)
23% less capital invested
Capital invested by funds: $165M → $127M (-$37.3M)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
+$2.72M |
| 2 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$2.22M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.04M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.04M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$7.93M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$2.04M |
| 3 |
Renaissance Technologies
New York
|
-$1.03M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.02M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$787K |
FOMX Hedge Fund Activity: Q3 2015 in Review
77 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) for Q3 2015, worth a combined $127M — down 23% from $165M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FOMX and 7 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 41 added.
The largest buyer was Cadian Capital Management, opening a new position worth an estimated $2.72M. The largest seller was Visium Asset Management, exiting entirely with an estimated $7.93M sold.
- 77 institutional investors held Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) as of Q3 2015, down from 84 in Q2 2015.
- Funds reported $127M of Foamix Pharmaceuticals Ltd. Ordinary Shares stock for Q3 2015, down 23% quarter-over-quarter.
- 7 funds opened new Foamix Pharmaceuticals Ltd. Ordinary Shares positions in Q3 2015 and 14 closed out, a net change of -7 holders.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares buyer in Q3 2015 was Cadian Capital Management, an estimated $2.72M added.
- The largest Foamix Pharmaceuticals Ltd. Ordinary Shares seller in Q3 2015 was Visium Asset Management, an estimated $7.93M sold.
Based on aggregated 13F filings for Q3 2015.